Business Description
Dianthus Therapeutics is a New York-based company founded in 2019 that focuses on treating serious autoimmune conditions through cutting-edge medical research. The company is advancing two promising drug candidates: one that precisely targets a key part of the immune system's complement pathway, and another that works in two ways at once to dial down harmful immune activity in certain white blood cells. Together, these treatments aim to offer new hope to patients whose immune systems attack their own bodies.
